ACR适宜性标准:非缺血性心肌病(已排除缺血性心肌病)
该指南按五种非缺血性心肌病变异型给出影像学适宜性推荐:变异型1、3、4的静息经胸超声心动图、心脏MRI(含和不含对比剂)均为通常适宜;变异型2和5的静息经胸超声心动图与含对比剂心脏MRI为通常适宜。指南基于文献分析与RAND/UCLA适宜性方法及GRADE分级制定,证据不足时辅以专家意见。
要点
- 变异型1、3、4:静息经胸超声心动图、心脏MRI含和不含对比剂均为通常适宜。
- 变异型2、5:静息经胸超声心动图与含对比剂心脏MRI为通常适宜。
- 指南采用RAND/UCLA适宜性方法与GRADE分级,证据不足时辅以专家意见。
核心结论
- 非缺血性心肌病分为五种变异型,各变异型的通常适宜影像学检查不同。
- 变异型1、3、4的通常适宜检查为静息经胸超声心动图、心脏MRI含和不含对比剂。
- 变异型2、5的通常适宜检查为静息经胸超声心动图与含对比剂心脏MRI。
研究设计与样本
- 美国放射学会适宜性标准,针对特定临床情况,由多学科专家组每年审阅。
- 指南制定与修订包括对同行评议期刊当前医学文献的广泛分析。
- 采用RAND/UCLA适宜性方法与GRADE对影像和治疗程序的适宜性进行评级。
- 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
诊断标准与关键数值
- 变异型1(肥厚型心肌病)、变异型3(扩张型或未分类心肌病)、变异型4(致心律失常性心肌病):静息经胸超声心动图、心脏MRI含和不含对比剂均为通常适宜。
- 变异型2(限制型或浸润型心肌病)、变异型5(炎症型心肌病):静息经胸超声心动图与含对比剂心脏MRI为通常适宜。
局限性
- 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Variant 1), restrictive or infiltrative cardiomyopathy (Variant 2), dilated or unclassified cardiomyopathy (Variant 3), arrhythmogenic cardiomyopathy (Variant 4), and inflammatory cardiomyopathy (Variant 5). For variants 1, 3, and 4, resting transthoracic echocardiography, MRI heart function and morphology without and with contrast, and MRI heart function and morphology without contrast are the usually appropriate imaging modalities. For variants 2 and 5, resting transthoracic echocardiography and MRI heart function and morphology without and with contrast are the usually appropriate imaging modalities. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Rajiah P, Kirsch J, Bolen MA, et al. ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestations (Ischemic Cardiomyopathy Already Excluded). J Am Coll Radiol. 2021. PMID: 33651982. doi:10.1016/j.jacr.2021.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。